logo
London Marathon: The Sussex runners taking on the 26.2 mile course

London Marathon: The Sussex runners taking on the 26.2 mile course

BBC News25-04-2025
Three determined Sussex runners have shared their different reasons for taking part in the London Marathon.More than 56,000 people are expected to take on the 26.2 mile (42.2 km) course on Sunday.The route passes Cutty Sark and Canary Wharf before finishing on The Mall, close to Buckingham Palace.Becki Malloy, Bethany Wood and Jon Carter explain what motivates them to take on the challenge.
Becki Malloy
Becki Malloy, from Horsham, will be running the London Marathon for the National Brain Appeal. Her father was diagnosed with early onset Alzheimer's at the age of 52 and she carries the same gene, which means she is very likely to develop the disease at a similar age.She said: "Running the London Marathon was on my bucket list so I took the crazy leap to do it."It was devastating when I found out what had happened to my dad but at the time I was quite naive, I thought it was an older person's disease."He couldn't remember me but he was still there."He father passed way last year.
Ms Malloy says she hopes the money raised will help University College London to find a cure and support people when a diagnosis is given.She has previously completed half marathons but said the training has been "a lot harder" than she thought it would be."I've chafed in places I never thought I would," she said. Ms Malloy said the training takes over "everything", adding: "I can't say I'll be running another one too soon afterwards."
Bethany Wood
Bethany Wood decided to run for the Cystic Fibrosis Trust as she has the condition. Cystic fibrosis is a genetic condition, causing the body's organs fill up with mucus, often with the lungs being affected the most. She wants to show people with cystic fibrosis that "life can go on and you can still go and do amazing things".Ms Wood said: "It also affects your pancreas, so a large number of people with cystic fibrosis also have diabetes as they don't have insulin like the standard person."
The London Marathon will be Ms Wood's 10th marathon in just 10 weeks.The mother-of-two says it is part of a big legacy challenge she is undertaking."I think my body will be screaming at me by the London Marathon," she said."I can't wait to finish and get home and take my shoes off and have a glass of wine for the first time in 10 months. I also can't wait to run a 5k in my local park."This is her second London Marathon.The first time she completed it, she gave the medal to her eldest daughter.She says she will be giving this medal to her other daughter.
Jon Carter
Jon Carter is running to support his son, Ethan, who has arthrogryposis multiplex congenita (AMC), a rare congenital condition affecting joint mobility.He said the charity he is supporting - Whizz Kidz - has changed his family's life.He said: "My son has been a in a wheelchair since he was born. "He is an absolutely amazing character and so persevering, but I want to show him through hard work you can achieve more than you expect."The charity has provided his son with an electric wheelchair, which he is able to control himself, meaning he does not people to push him around anymore.
Mr Carter admitted that he "doesn't like running".He said: "I'm really pushing myself to do this."Audio books have helped me a lot through my long runs in training. "It's been hard work. I'll probably collapse when I have finished but we have planned to have a fish and chip dinner as a treat when we get home."
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Cats develop dementia similarly to humans
Cats develop dementia similarly to humans

Leader Live

timea day ago

  • Leader Live

Cats develop dementia similarly to humans

Experts at the University of Edinburgh carried out a post-mortem brain examination on 25 cats which exhibited symptoms of dementia in life, including confusion, sleep disruption and an increase in vocalisation, in a bid explore new treatments for humans. Previously, researchers have studied genetically modified rodents, although the species does not naturally suffer from dementia. In feline dementia brains, a build-up was found of amyloid-beta, a toxic protein and one of the defining features of Alzheimer's disease, leading to hopes of a 'wonderful' breakthrough due to increased accuracy. The breakthrough was hailed as a 'perfect natural model for Alzheimer's' by scientists who worked on it. Microscopy images revealed a build-up of amyloid-beta within synapses of older cats and feline dementia, and scientists hope the findings offer a clearer idea of how amyloid-beta may lead to feline cognitive dysfunction and memory loss, offering a valuable model for studying dementia in people. Synapses allow the flow of messages between brain cells, and losing these causes reduced memory and thinking abilities in humans with Alzheimer's. Researchers found evidence that brain support cells, astrocytes and microglia, engulfed the affected synapses, known as synaptic pruning, an important process during brain development but which contributes to dementia. Experts believe the findings could contribute to the development of new treatments for Alzheimer's disease, as well as help to understand and manage feline dementia. Previously, scientists studying Alzheimer's relied on genetically modified rodent models. However, studying feline dementia has the potential to help develop human treatments, due to increased accuracy, it is hoped. The study, funded by Wellcome and the UK Dementia Research Institute, is published in the European Journal of Neuroscience, and included scientists from the Universities of Edinburgh and California, UK Dementia Research Institute and Scottish Brain Sciences. Dr Robert McGeachan, study lead from the University of Edinburgh's Royal (Dick) School of Veterinary Studies, said: 'Dementia is a devastating disease – whether it affects humans, cats, or dogs. Our findings highlight the striking similarities between feline dementia and Alzheimer's disease in people. 'This opens the door to exploring whether promising new treatments for human Alzheimer's disease could also help our ageing pets. 'Because cats naturally develop these brain changes, they may also offer a more accurate model of the disease than traditional laboratory animals, ultimately benefiting both species and their caregivers.' Professor Danielle Gunn-Moore, personal chair of Feline Medicine at the Royal (Dick) School of Veterinary Studies, said: 'Feline dementia is so distressing for the cat and for its person. 'It is by undertaking studies like this that we will understand how best to treat them. This will be wonderful for the cats, their owners, people with Alzheimer's and their loved ones. 'Feline dementia is the perfect natural model for Alzheimer's – everyone benefits.'

Students fast tracked for autism diagnosis while children wait years
Students fast tracked for autism diagnosis while children wait years

Telegraph

timea day ago

  • Telegraph

Students fast tracked for autism diagnosis while children wait years

University students will be fast-tracked for autism diagnosis while children continue to wait years, The Telegraph can reveal. Students will be taken out of the regular local services amid surging referrals for young people, according to a trial at University College London starting in the upcoming academic year. Those still on the current waiting lists will still have to wait several years while students use the dedicated service. The NHS is providing £80,000 in funding to UCL, which is setting up a first-of-its-kind autism clinic to focus solely on students. The university-specific NHS clinic will investigate if the approach improves wait list times for both the general population as well as students during the course of the project from October 2025 until November 2026. Officials have said university students pose a 'specific challenge to the dynamics of adult waiting lists' because students can spend longer waiting for an appointment than the length of a degree. This serves to inflate waiting times for the general public in the neighbouring area as well as failing the student, officials say. There has been a 15-fold increase in the number of 18-24 year-olds seeking an appointment for an autism diagnosis since 2019, official data show. Demand for specialist clinics has soared since the Covid-19 pandemic as a result of increased awareness of autism symptoms, often driven by social media. The huge waiting lists mean people often wait several years to be seen by a clinician and get a diagnosis. This overburdening of autism services is forcing individuals with profound autism who require 24/7 care, including non verbal people, to suffer serious delays to their treatment with lifelong ramifications. In the contract between the NHS England and UCL, officials wrote: 'Removing student populations from local specialist autism teams could positively impact the waiting list.' A recent report found that almost a third of self-harm and suicide cases among university students involve neurodiverse individuals, including those with ADHD and autism Autism waiting lists have ballooned in recent years for all ages but most noticeably in under-25s. Telegraph analysis reveals that there were more than a quarter of a million people awaiting an appointment for a diagnosis in March 2025, the most recent available data, up from 17,400 in April 2019. Almost 75,000 children under 10 are on the waiting list, up more than 12-fold in six years from less than 6,000. There are almost 91,000 people between 10 and 25 currently awaiting a referral, up 12-fold from 7,700 pre-pandemic. In contrast, there are just 735 over-65s on the waiting list. However, this is up more than 11-fold itself from just 65 in 2019. An NHS England spokesman told The Telegraph: 'Backed by NHS funding, University College London is trialling a first-of-its-kind dedicated autism clinic and assessment referral pathway for university students. 'The aim is to test whether separating students from the mainstream waiting list leads to faster diagnosis and better support during the often-challenging transition to higher education. 'The project will also identify ways to improve how autistic and neurodivergent students are supported during university, as well as looking for ways to improve NHS services for autistic people more generally.' The system will only be open to UCL students as part of the pilot programme. A UCL spokesman said: 'The project has a number of aims including to pilot and evaluate a referral pathway for UCL students, so that if they suspect they are autistic, they can get a timely assessment at UCL. 'Given current waiting lists in NHS adult services, some people needing autism assessment at university cannot get their assessment until after they graduate.' Other goals of the project are to improve support that can be offered to autistic students and also improve training to clinicians. The UCL spokesman added: 'It is intended that this research will generate a range of new ideas for improving the effectiveness and efficiency of autism services, that can be adopted in settings across the country, such as NHS autism assessment clinics and general mental health services. 'This has the potential to contribute to improvements in the quality of services and waiting times nationally.' 'Diagnosis can be lifesaving' Mel Merritt, the head of policy and campaigns at the National Autistic Society, said: 'This trial is an opportunity to provide faster diagnosis and better support for autistic university students. 'An autism diagnosis is often life changing and can be lifesaving. University is an important transitional time for many young autistic people and it's important they receive a timely diagnosis so they can get the right support. 'Nine in 10 people wait longer than the recommended 13 weeks and the average wait time is more than 14 months, with many waiting years. 'Without a diagnosis, avoidable crises can develop and, while it shouldn't be the case, often support isn't provided until someone has a diagnosis. At school, this means children and young people miss out on years of their education. 'The Government must provide urgent funding for diagnosis services across the country to end this worsening crisis, and make sure autistic people and their families get the support they need.'

Cats develop dementia similarly to humans
Cats develop dementia similarly to humans

Rhyl Journal

timea day ago

  • Rhyl Journal

Cats develop dementia similarly to humans

Experts at the University of Edinburgh carried out a post-mortem brain examination on 25 cats which exhibited symptoms of dementia in life, including confusion, sleep disruption and an increase in vocalisation, in a bid explore new treatments for humans. Previously, researchers have studied genetically modified rodents, although the species does not naturally suffer from dementia. In feline dementia brains, a build-up was found of amyloid-beta, a toxic protein and one of the defining features of Alzheimer's disease, leading to hopes of a 'wonderful' breakthrough due to increased accuracy. The breakthrough was hailed as a 'perfect natural model for Alzheimer's' by scientists who worked on it. Microscopy images revealed a build-up of amyloid-beta within synapses of older cats and feline dementia, and scientists hope the findings offer a clearer idea of how amyloid-beta may lead to feline cognitive dysfunction and memory loss, offering a valuable model for studying dementia in people. Synapses allow the flow of messages between brain cells, and losing these causes reduced memory and thinking abilities in humans with Alzheimer's. Researchers found evidence that brain support cells, astrocytes and microglia, engulfed the affected synapses, known as synaptic pruning, an important process during brain development but which contributes to dementia. Experts believe the findings could contribute to the development of new treatments for Alzheimer's disease, as well as help to understand and manage feline dementia. Previously, scientists studying Alzheimer's relied on genetically modified rodent models. However, studying feline dementia has the potential to help develop human treatments, due to increased accuracy, it is hoped. The study, funded by Wellcome and the UK Dementia Research Institute, is published in the European Journal of Neuroscience, and included scientists from the Universities of Edinburgh and California, UK Dementia Research Institute and Scottish Brain Sciences. Dr Robert McGeachan, study lead from the University of Edinburgh's Royal (Dick) School of Veterinary Studies, said: 'Dementia is a devastating disease – whether it affects humans, cats, or dogs. Our findings highlight the striking similarities between feline dementia and Alzheimer's disease in people. 'This opens the door to exploring whether promising new treatments for human Alzheimer's disease could also help our ageing pets. 'Because cats naturally develop these brain changes, they may also offer a more accurate model of the disease than traditional laboratory animals, ultimately benefiting both species and their caregivers.' Professor Danielle Gunn-Moore, personal chair of Feline Medicine at the Royal (Dick) School of Veterinary Studies, said: 'Feline dementia is so distressing for the cat and for its person. 'It is by undertaking studies like this that we will understand how best to treat them. This will be wonderful for the cats, their owners, people with Alzheimer's and their loved ones. 'Feline dementia is the perfect natural model for Alzheimer's – everyone benefits.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store